Empowering People with Diabetes: Improving Perceptions and Outcomes with Technical Advances in Insulin Pens

References

• . Intensive blood–glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837–853
   PubMed Web of Science ®Google Scholar
• . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977–986
   PubMed Web of Science ®Google Scholar
• . Brod M, Kongsø JH, Lessard S, Christensen TL. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res. 2009;18(1):23–32
   PubMed Web of Science ®Google Scholar
• . Peyrot M, Rubin RR, Lauritzen T, ; International DAWN Advisory Panel. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care. 2005;28(11):2673–2679
   PubMed Web of Science ®Google Scholar
• . Peyrot M, Rubin RR, Kruger DF, Travis LB. Correlates of insulin injection omission. Diabetes Care. 2010;33(2):240–245
   PubMed Web of Science ®Google Scholar
• . Bashoff EC, Beaser RS. Insulin therapy and the reluctant patient. Overcoming obstacles to success. Postgrad Med. 1995;97(2):86–90, 93–96
   PubMed Web of Science ®Google Scholar
• . Korytkowski M, Niskanen L, Asakura T. FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther. 2005;27( suppl B):S89–S100
   PubMed Web of Science ®Google Scholar
• . Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study. Diabet Med. 2005;22(10):1379–1385
   PubMed Web of Science ®Google Scholar
• . Bohannon NJ, Ohannesian JP, Burdan AL, Holcombe JH, Zagar A. Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0-mL prefilled pen device for insulin delivery. Clin Ther. 2000;22(9):1049–1067
   PubMed Web of Science ®Google Scholar
• . Korytkowski M, Bell D, Jacobsen C, Suwannasari R; FlexPen Study Team. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther. 2003;25(11):2836–2848
   PubMed Web of Science ®Google Scholar
• . Mollema ED, Snoek FJ, Adèr HJ, Heine RJ, van der Ploeg HM. Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing: psychological comorbidity and general well-being. J Psychosom Res. 2001;51(5):665–672
   PubMed Web of Science ®Google Scholar
• . Mollema ED, Snoek FJ, Heine RJ, van der Ploeg HM. Phobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screening. Diabet Med. 2001;18(8):671–674
   PubMed Web of Science ®Google Scholar
• . Zambanini A, Newson RB, Maisey M, Feher MD. Injection related anxiety in insulin-treated diabetes. Diabetes Res Clin Pract. 1999;46(3):239–246
   PubMed Web of Science ®Google Scholar
• . Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance. Diabetes Care. 1997;20(3):292–298
   PubMed Web of Science ®Google Scholar
• . Hamilton JG. Needle phobia: a neglected diagnosis. J Fam Pract. 1995;41(2):169–175
   PubMed Web of Science ®Google Scholar
• . Hirsch LJ, Gibney MA, Albanese J, . Comparative glycemic control, safety and patient ratings for a new 4 mm × 32G insulin pen needle in adults with diabetes. Curr Med Res Opin. 2010;26(6): 1531–1541
   PubMed Web of Science ®Google Scholar
• . Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila). 2004;43(1):69–74
   PubMed Web of Science ®Google Scholar
• . Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care. 1999;22(1): 137–140
   PubMed Web of Science ®Google Scholar
• . Coscelli C, Lostia S, Lunetta M, Nosari I, Coronel GA. Safety, efficacy, acceptability of a pre-filled insulin pen in diabetic patients over 60 years old. Diabetes Res Clin Pract. 1995;28(3):173–177
   PubMed Web of Science ®Google Scholar
• . Bohannon NJ. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med. 1999;106(5):57–58, 61–64, 68
   PubMed Web of Science ®Google Scholar
• . Chantelau E, Schiffers T, Schütze J, Hansen B. Effect of patient-selected intensive insulin therapy on quality of life. Patient Educ Couns. 1997;30(2):167–173
   PubMed Web of Science ®Google Scholar
• . Kadiri A, Chraibi A, Marouan F, Ababou MR, el Guermai N, Wadjinny A, . Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents. Diabetes Res Clin Pract. 1998;41(1):15–23
   PubMed Web of Science ®Google Scholar
• . Albano S; Orbiter Study Group. Assessment of quality of treatment in insulin-treated patients with diabetes using a pre-filled insulin pen. The ORBITER Study Group. Acta BioMed. 2004;75(1):34–39
   PubMedGoogle Scholar
• . Lombardo F, Salzano G, Messina MF, De Luca F. Compliance and administration methods in management of type 1 diabetes. Acta BioMed. 2005;76( suppl 3):66–69
   PubMedGoogle Scholar
• . Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther. 2004;26(9):1498–1505
   PubMed Web of Science ®Google Scholar
• . Stockl K, Ory C, Vanderplas A, . An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Curr Med Res Opin. 2007;23(1):133–146
   PubMed Web of Science ®Google Scholar
• . Fox C, McKinnon C, Wall A, Lawton A. Ability to handle, and patient preference for, insulin delivery devices in visually impaired patients with type 2 diabetes. Pract Diabetes Int. 2002;19(4):104–107
   Google Scholar
• . Graff MR, McClanahan MA. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther. 1998;20(3):486–496
   PubMed Web of Science ®Google Scholar
• . Sucic M, Galic E, Cabrijan T, . Patient acceptance and reliability of new Humulin/Humalog 3.0 mL preflled insulin pen in ten Croatian diabetes centres. Med Sci Monit. 2002;8(3):PI21–PI26
   PubMedGoogle Scholar
• . Dunbar JM, Madden PM, Gleeson DT, Fiad TM, McKenna TJ. Premixed insulin preparations in pen syringes maintain glycemic control and are preferred by patients. Diabetes Care. 1994;17(8): 874–878
   PubMed Web of Science ®Google Scholar
• . Corsi A, Torre E, Coronel G, . Pre-filled insulin pen in newly insulin-treated diabetic patients over 60 years old. Diab Nutr Metab. 1997;10(2):78–81
   Google Scholar
• . Shelmet J, Schwartz S, Cappleman J, ; InnoLet Study Group. Preference and resource utilization in elderly patients: InnoLet versus vial/syringe. Diabetes Res Clin Pract. 2004;63(1):27–35
   PubMed Web of Science ®Google Scholar
• . de Luis DA, Aller R, Cuellar L, . Effect on quality of life with a new insulin injection device in elderly patients with diabetes mellitus type 2. J Diabetes Complications. 2004;18(4):216–219
   PubMed Web of Science ®Google Scholar
• . Asamoah E. Insulin pen—the “iPod” for insulin delivery (why pen wins over syringe). J Diabetes Sci Technol. 2008;2(2):292–296
   PubMedGoogle Scholar
• . Ignaut DA, Schwartz SL, Sarwat S, Murphy HL. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen. Diabetes Educ. 2009;35(5):789–798
   PubMed Web of Science ®Google Scholar
• . Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther. 2006;28(10):1712–1725; discussion 1710–1711
   PubMed Web of Science ®Google Scholar
• . Cobden D, Lee WC, Balu S, Joshi AV, Pashos CL. Health outcomes and economic impact of therapy conversion to a biphasic insulin analog pen among privately insured patients with type 2 diabetes mellitus. Pharmacotherapy. 2007;27(7):948–962
   PubMed Web of Science ®Google Scholar
• . Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Clin Ther. 2007;29(spec no):1294–1305
   Web of Science ®Google Scholar
• . Clarke A, Spollett G. Dose accuracy and injection force dynamics of a novel disposable insulin pen. Expert Opin Drug Deliv. 2007;4(2):165–174
   PubMed Web of Science ®Google Scholar
• . Penfornis A, Horvat K. Dose accuracy comparison between SoloSTAR and FlexPen at three different dose levels. Diabetes Technol Ther. 2008;10(5):359–362
   PubMed Web of Science ®Google Scholar
• . Asakura T, Seino H, Kageyama M, Yohkoh N. Dosing accuracy of two insulin pre-filled pens. Curr Med Res Opin. 2008;24(5): 1429–1434
   PubMed Web of Science ®Google Scholar
• . Pfützner A, Reimer T, Hohberg C, Frøkjaer LP, Jørgensen C. Prefilled insulin device with reduced injection force: patient perception and accuracy. Curr Med Res Opin. 2008;24(9):2545–2549
   PubMed Web of Science ®Google Scholar
• . Weise A, Pfützner JW, Borig J, . Comparison of the dose accuracy of prefilled insulin pens. J Diabetes Sci Technol. 2009;3(1): 149–153
   PubMedGoogle Scholar
• . Hänel H, Weise A, Sun W, Pfützner JW, Thomé N, Pfützner A. Differences in the dose accuracy of insulin pens. J Diabetes Sci Technol. 2008;2(3):478–481
   PubMedGoogle Scholar
• . Ignaut DA, Opincar MR, Clark PE, Palaisa MK, Lenox SM. Engineering study comparing injection force and dose accuracy between two prefilled insulin injection pens. Curr Med Res Opin. 2009;25(12): 2829–2833
   PubMed Web of Science ®Google Scholar
• . Krzywon M, Abdel–Tawab M, van der Burg T, Fuhr U, Schubert–Zsilavecz M. Dosing accuracy of commonly used disposable insulin pens. Curr Med Res Opin. 2010;26(4):901–905
   PubMed Web of Science ®Google Scholar
• . Krzywon M, van der Burg T, Fuhr U, Schubert–Zsilavecz M, Abdel–Tawab M. Study on the dosing accuracy of commonly used disposable insulin pens. Diabetes Technol Ther. 2012;14(9):804–809
   PubMed Web of Science ®Google Scholar
• . Wielandt JO, Niemeyer M, Hansen MR, Bucher D, Thomsen NB. FlexTouch: a prefilled insulin pen with a novel injection mechanism with consistent, high accuracy at low- (1 U), medium-(40 U), and high- (80 U) dose settings. J Diabetes Sci Technol. 2011;5(5):1195–1199
   PubMedGoogle Scholar
• . Wielandt JO, Niemeyer M, Hansen MR, Bucher D, Thomsen NB. An assessment of dose accuracy and injection force of a novel prefilled insulin pen: comparison with a widely used prefilled insulin pen. Expert Opin Drug Deliv. 2011;8(10):1271–1276
   PubMed Web of Science ®Google Scholar
• . Hermanns N, Kulzer B, Haak T. Dosing accuracy with a novel pen device (SoloSTAR) as performed by patients with diabetes in a clinical setting. Diabetes Technol Ther. 2008;10(4):322–327
   PubMed Web of Science ®Google Scholar
• . Friedrichs A. Dose accuracy of SoloSTAR and FlexPen as assessed in a clinical setting. Diabetes Technol Ther. 2009;11(9):609–613
   PubMed Web of Science ®Google Scholar
• . Hemmingsen H, Niemeyer M, Hansen MR, Bucher D, Thomsen NB. A prefilled insulin pen with a novel injection mechanism and a lower injection force than other prefilled insulin pens. Diabetes Technol Ther. 2011;13(12):1207–1211
   PubMed Web of Science ®Google Scholar
• . Lefkowitz M. Do different body colors and labels of insulin pens enhance a patient's ability to correctly identify pens for injecting long-acting versus short-acting insulins? J Diabetes Sci Technol. 2011;5(1):136–149
   PubMedGoogle Scholar
• . Asche CV, Shane–McWhorter L, Raparla S. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence. Diabetes Technol Ther. 2010;12( suppl 1):S101–S108
   PubMed Web of Science ®Google Scholar
• . Campos C, Lajara R, Deluzio T. Usability and preference assessment of a new prefilled insulin pen versus vial and syringe in people with diabetes, physicians and nurses. Expert Opin Pharmacother. 2012;13(13):1837–1846
   PubMed Web of Science ®Google Scholar
• . Hancu N, Czupryniak L, Genestin E, Sourij H. A Pan-European and Canadian prospective survey to evaluate patient satisfaction with the SoloSTAR insulin injection device in type 1 and type 2 diabetes. J Diabetes Sci Technol. 2011;5(5):1224–1234
   PubMedGoogle Scholar
• . Fischer JS, Edelman SV, Schwartz SL. United States patient preference and usability for the new disposable insulin device Solostar versus other disposable pens. J Diabetes Sci Technol. 2008;2(6):1157–1160
   PubMedGoogle Scholar
• . Clark PE, Valentine V, Bodie JN, Sarwat S. Ease of use and patient preference injection simulation study comparing two prefilled insulin pens. Curr Med Res Opin. 2010;26(7):1745–1753
   PubMed Web of Science ®Google Scholar
• . Garg S, Bailey T, DeLuzio T, Pollom D. Preference for a new prefilled insulin pen compared with the original pen. Curr Med Res Opin. 2011; 27(12):2323–2333
   PubMed Web of Science ®Google Scholar
• . Oyer D, Narendran P, Qvist M, Niemeyer M, Nadeau DA. Ease of use and preference of a new versus widely available prefilled insulin pen assessed by people with diabetes, physicians and nurses. Expert Opin Drug Deliv. 2011;8(10):1259–1269
   PubMed Web of Science ®Google Scholar
• . Bailey T, Thurman J, Niemeyer M, Schmeisl G. Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals. Curr Med Res Opin. 2011;27(10):2043–2052
   PubMed Web of Science ®Google Scholar
• . Nadeau DA, Campos C, Niemeyer M, Bailey T. Healthcare professional and patient assessment of a new prefilled insulin pen versus two widely available prefilled insulin pens for ease of use, teaching and learning. Curr Med Res Opin. 2012;28(1):3–13
   PubMed Web of Science ®Google Scholar
• . Carter J, Beilin J, Morton A, De Luise M. Usability, participant acceptance, and safety of a prefilled insulin injection device in a 3-month observational survey in everyday clinical practice in Australia. J Diabetes Sci Technol. 2009;3(6):1425–1438
   PubMedGoogle Scholar
• . Sommavilla B, Jørgensen C, Jensen KH. Safety, simplicity and convenience of a modified prefilled insulin pen. Expert Opin Pharmacother. 2008;9(13):2223–2232
   PubMed Web of Science ®Google Scholar
• . Arslanoǧlu I, Saka N, Bundak R, Günöz H, Darendeliler F. A comparison of the use of premixed insulins in pen-injectors with conventional patient-mixed insulin treatment in children and adolescents with IDDM. Is there a decreased risk of night hypoglycemia? J Pediatr Endocrinol Metab. 2000;13(3):313–318
   PubMed Web of Science ®Google Scholar
• . Berger AS, Saurbrey N, Kühl C, Villumsen J. Clinical experience with a new device that will simplify insulin injections. Diabetes Care. 1985;8(1):73–76
   PubMed Web of Science ®Google Scholar
• . Hanas R, Ludvigsson J. Experience of pain from insulin injections and needle-phobia in young patients with IDDM. Pract Diabetes Int. 1997;14(4):95–99
   Google Scholar
• . Kølendorf K, Beck–Nielsen H, Oxenbøll B. Clinical experience with NovoPen II and insulin Protaphane HM Penfill. Postgrad Med J. 1988;64( suppl 3):14–16; discussion 21
   PubMed Web of Science ®Google Scholar
• . Joslin Diabetes Center website. Writing prescriptions for monitors, insulin, syringes, pens and pen needles. http://www.bd.com/us/diabetes/hcp/main.aspx?cat=3065&id=63268. Accessed August 8, 2012
   Google Scholar
• . Egekvist H, Bjerring P, Arendt–Nielsen L. Pain and mechanical injury of human skin following needle insertions. Eur J Pain. 1999;3(1): 41–49
   PubMed Web of Science ®Google Scholar
• . Siegmund T, Blankenfeld H, Schumm–Draeger PM. Comparison of usability and patient preference for insulin pen needles produced with different production techniques: “thin–wall” needles compared to “regular–wall” needles: an open-label study. Diabetes Technol Ther. 2009;11(8):523–528
   PubMed Web of Science ®Google Scholar
• . Hirsch L, Gibney M, Berube J, Manocchio J. Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes. J Diabetes Sci Technol. 2012;6(2):328–335
   PubMedGoogle Scholar
• . Hofman P, Lilleøre SK, Ter–Borch G. Needle with a novel attachment versus conventional screw-thread needles: a preference and ease of use test among children and adolescents with diabetes. J Diabetes Sci Technol. 2011;5(6):1480–1487
   PubMedGoogle Scholar
• . Molife C, Lee LJ, Shi L, Sawhney M, Lenox SM. Assessment of patient-reported outcomes of insulin pen devices versus conventional vial and syringe. Diabetes Technol Ther. 2009;11(8): 529–538
   PubMed Web of Science ®Google Scholar
• . Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care. 2004;27(10):2495–2497
   PubMed Web of Science ®Google Scholar
• . Davis EM, Christensen CM, Nystrom KK, Foral PA, Destache C. Patient satisfaction and costs associated with insulin administered by pen device or syringe during hospitalization. Am J Health Syst Pharm. 2008;65(14):1347–1357
   PubMed Web of Science ®Google Scholar
• . Lajara R, Guerrero G, Thurman J. Healthcare professional and patient perceptions of a new prefilled insulin pen versus vial and syringe [published online ahead of print September 13, 2012]. Expert Opin Drug Deliv
   Google Scholar
• . Peyrot M, Barnett AH, Meneghini LF, Schumm–Draeger PM. Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study. Diabet Med. 2012;29(5):682–689
   PubMed Web of Science ®Google Scholar
• . Lee IT, Liu HC, Liau YJ, Lee WJ, Huang CN, Sheu WH. Improvement in health-related quality of life, independent of fasting glucose concentration, via insulin pen device in diabetic patients. J Eval Clin Pract. 2009;15(4):699–703
   PubMed Web of Science ®Google Scholar
• . Nicolucci A, Cucinotta D, Squatrito S, ; QuoLITy Study Group. Clinical and socio-economic correlates of quality of life and treatment satisfaction in patients with type 2 diabetes. Nutr Metab Cardiovas Dis. 2009;19(1):45–53
   PubMed Web of Science ®Google Scholar
• . Rubin RR, Peyrot M. Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care. 2008;31(3):430–432
   PubMed Web of Science ®Google Scholar
• . Dyck PJ, Kratz KM, Karnes JL, . The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43(4):817–824
   PubMed Web of Science ®Google Scholar
• . Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC. Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology. 1995;45(6):1115–1121
   PubMed Web of Science ®Google Scholar
• . Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther. 2008;120(1):1–34
   PubMed Web of Science ®Google Scholar
• . Pfützner A, Musholt PB, Schipper C, . Self-assessment and objective determination of dexterity in patients with type 1 or type 2 diabetes mellitus. Curr Med Res Opin. 2012;28(1):15–21
   PubMed Web of Science ®Google Scholar
• . Schipper C, Musholt P, Niemeyer M, . Patient device assessment evaluation of two insulin injection devices in a mixed cohort of insulin-treated patients with type 1 or type 2 diabetes mellitus. Curr Med Res Opin. 2012;28(8):1297–1303
   PubMed Web of Science ®Google Scholar
• . Hansen B, Lilleøre SK, Ter–Borch G. Needle with a novel attachment versus conventional screw-thread needles: a preference and usability test among adults with diabetes and impaired manual dexterity. Diabetes Technol Ther. 2011;13(5):579–585
   PubMed Web of Science ®Google Scholar
• . van der Burg T. Injection force of SoloSTAR® compared with other disposable insulin pen devices at constant volume flow rates. J Diabetes Sci Technol. 2011;5(1):150–155
   PubMedGoogle Scholar